ArticleJournal of cardiothoracic surgery2026
Prognostic factors in resected non-small cell lung cancer with pathological N1 lymph node involvement: a survival analysis.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the prognostic factors influencing survival in patients who underwent surgical treatment for early-stage non-small cell lung cancer (NSCLC) and were found to have N1 lymph node metastasis on pathological examination.
methodsA total of 66 NSCLC patients who underwent anatomic lung resection (lobectomy, bilobectomy, or pneumonectomy) at our clinic between 2010 and 2020 and had a pathological stage of T1-2N1M0 disease were retrospectively analyzed. Clinical, demographic, histopathological, and surgical data, as well as survival times, were evaluated. Survival analyses were performed via the Kaplan-Meier method, and prognostic variables were assessed via univariate and multivariate analyses.
resultsA total of 66 patients, 60 males and 6 females, were included in the study. The mean age was 63.7 ± 8.3 years. The mean overall survival was 59.7 months, and the disease-free survival was 52.0 months. Squamous cell carcinoma histology, central tumor location, the presence of occult lymph node metastasis, and visceral pleural invasion were significantly associated with survival (p < 0.05). Cox regression analysis revealed that the histological subtype and the visibility of N1 metastasis were identified as independent prognostic factors.
conclusionPathological N1 lymph node involvement has a significant effect on the prognosis of patients with NSCLC. In particular, histological subtype and the presence of occult metastasis are key determinants of survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.